Search for Clinical Trial Results

Sponsored By

Porphyria Cutanea Tarda - 25 Studies Found

Status Study
Completed Study Name: Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Date: 2005-09-13
Completed Study Name: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2008-01-10
Interventions: Drug: Deferasirox 250 mg of deferasirox once daily for 6 months
Recruiting Study Name: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2012-04-05
Interventions:
  • Drug: Hydroxychloroquine 100 m
Recruiting Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2011-01-26
Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b
Completed Study Name: Study of the Pathogenesis of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Date: 2000-04-06
Not yet recruiting Study Name: Harvoni Treatment Porphyria Cutanea Tarda
Condition:
  • Porphyria Cutanea Tarda
  • Hepatitis C

Date: 2017-04-13
Interventions: Drug: Harvoni One capsule of Harvoni/ ledipasvir, 90 mg + sofosbuvir, 400 mg administered daily for 8, 1
Active, not recruiting Study Name: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition: Acute Hepatic Porphyria
Date: 2014-09-11
Recruiting Study Name: Oral Iron for Erythropoietic Protoporphyrias
Condition:
  • Erythropoietic Protoporphyria
  • EPP
  • X-linked Protoporphyria<
    Date: 2016-11-29
    Interventions: Drug: Oral Iron for one year Other Name: Ferrous sul
Recruiting Study Name: Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Condition:
  • Erythropoietic Protoporphyria
  • EPP
  • X-Linked Protoporphyria<
    Date: 2012-09-14
Recruiting Study Name: Phase III Confirmatory Study in Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Date: 2012-05-22
Interventions:
  • Drug: Afamelanotide One 16mg s
Next >>>